Articles tagged "Pancreas transplantation"

2016 American Transplant Congress
Pancreatic Allograft Failure in Latino Recipients: Diabetes Mellitus Type 2 Conversion?
H. Fernandez, G. McKenna, N. Onaca, R. Ruiz.
Baylor University Medical Center, Dallas, TX.
Introduction:Pancreas transplantation is the definitive treatment for diabetes mellitus (DM). The advantages of simultaneous kidney pancreas transplant in Latinos have been demonstrated previously, but there…
2016 American Transplant Congress
Transplantation of Islet Preconditioned with Hydrogen Sulfide Enhances the Graft Function in Diabetic Mice.
D. Wang, M. Ding, J. Xue, J. Zheng, S. Feng, H. Tian, Y. Li.
Department of Renal Transplant, Center of Nephropathy, the First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.
Background: Islet transplantation is a promising therapy for Type 1 diabetes. However, successful outcomes are hampered by the poor survival of the donor cells after…
2016 American Transplant Congress
Continuous Glucose Monitoring in the First 6 Weeks After Transplantation in Pancreas Transplant Recipients.
K. Bonner,¹ V. Dadlani,² P. Thapa,² M. Stegall,¹ Y. Kudva.²
¹Department of Surgery, Division of Transplant Surgery, Mayo Clinic, Rochester; ²Department of Medicine, Division of Endocrinology, Mayo Clinic, Rochester.
Introduction The maturation of Continuous glucose monitoring (CGM) technology enables accurate characterization of daily glucose control. We investigated glucose control using CGM in the first…
2016 American Transplant Congress
Potent Induction Therapy Improves Graft Outcome in Younger Pancreas Transplant Recipients (<30 Years of Age).
A. Gruessner, V. Whittaker, S. Narsipur, V. Aggarwal, C. Hubbel, R. Gruessner.
SUNY Upstate Medical University, Syracuse, NY.
Purpose: Pancreas transplants (tx) are increasingly performed in older patients with type 1 diabetes mellitus. This trend may be explained by the significantly higher immunologic…
2016 American Transplant Congress
Effect on Endothelial function when Hyperglycemia Is Reversed by Single Pancreas Transplantation.
T. Halden,^1,2 I. Eide,^1,2 D. Dahle,¹ A. Åsberg,^1,3 A. Reisæter,¹ T. Jenssen,^1,4 A. Hartmann.^1,2
¹Department of Transplant Medicine, Section of Nephrology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; ²Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; ³Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway; ⁴Metabolic and Renal Research Group, UiT, The Arctic University of Norway, Tromsø, Norway.
Background: Endothelial dysfunction is a predictor for future cardiovascular disease. We have previously published that endothelial function improves in renal transplant recipients with post-transplantation diabetes…
2016 American Transplant Congress
The Impact of One Year Individual or Dual Organ Rejection in Simultaneous Pancreas-Kidney Transplant on Kidney Graft Survival – A UNOS Registry Analysis 2000-2013.
I. Moinuddin,¹ T. Taber,¹ M. Yaqub,¹ O. Adebiyi,¹ M. Mujtaba,¹ J. Chen,² M. Goble,² D. Mishler,¹ J. Fridell,² A. Sharfuddin.¹
¹Medicine/Nephrology, Indiana University, Indianapolis; ²Surgery/Transplant, Indiana University, Indianapolis.
Background: Early Rejection of either organ in Simultaneous Pancreas-Kidney transplants (SPK) is common within the first 1 year. We studied the impact of within 1…
2016 American Transplant Congress
Pancreas Retransplantation – Is It Worth It?
M. Kocik,¹ K. Lipar,¹ L. Janousek,¹ P. Girman,² J. Fronek,¹ F. Saudek.²
¹Transplant Surgery Department, IKEM, Prague, Czech Republic; ²Department of Diabetes, IKEM, Prague, Czech Republic.
Background: Pancreas transplantation is well established therapy for insulin-dependent diabetic patients. Management of patients with failed graft by retransplantation might be associated with increased technical…
2016 American Transplant Congress
Impact of Early Acute Rejection (AR) on Pancreas Transplant (PT) Outcomes.
V. Kirchner, T. Dunn, A. Kukla, R. Kandaswamy, E. Finger.
University of Minnesota, Minneapolis.
Background: The role of early AR in long-term PT outcomes remains unclear. Despite reported high rate of AR (up to 40% in PTA), graft survival…
2016 American Transplant Congress
Virtual Crossmatch in Simultaneous Pancreas-Kidney Transplant.
E. Bevilaqua Rangel,¹ A. Miziara Gonzalez,¹ C. Santiago Melaragno,¹ J. de Sa,¹ M. Moura Linhares,¹ A. Salzedas-Neto,¹ R. de Marco,² M. de Lima,² J. Medina-Pestana.¹
¹Transplant Unit, Federal University of Sao Paulo, Sao Paulo, SP, Brazil; ²Histocompatibility Laboratory, Federal University of Sao Paulo, Sao Paulo, Brazil.
Background: Simultaneous pancreas-kidney transplant (SPKT) outcomes have improved over the years. Methods: Analyses of demographic data of patients submitted to SPKT from Dec/2000 to Sep/2015…
2016 American Transplant Congress
Antibody-Mediated Rejection in Pancreas Transplantation.
O. Serrano,¹ D. Vock,² E. Finger,¹ R. Kandaswamy,¹ D. Sutherland,¹ T. Dunn.¹
¹Surgery, Univ. of Minnesota, Minneapolis, MN; ²Biostatistics, University of Minnesota, Minneapolis, MN.
PURPOSE: The diagnostic criteria for antibody-mediated rejection (AMR) in pancreas transplantation (PTx) is evolving. The incidence and long-term effect of AMR have not been well-described.…